TheProfitWatch

SLS - SELLAS Life Sciences Group, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
1.45 0.07 (5.17%) 0.0 (-0.23%) 0.0 (-0.32%) 0.0 (0.33%) 0.08 (5.52%) 0.01 (0.99%) 0.01 (0.34%) 0.07 (4.79%)

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.07
Diluted EPS:
-0.07
Basic P/E:
-21.7857
Diluted P/E:
-21.7857
RSI(14) 1m:
50.0
VWAP:
1.53
RVol:

Events

Period Kind Movement Occurred At

Related News